297 related articles for article (PubMed ID: 31657237)
1. Midlife women's health consequences associated with polycystic ovary syndrome.
Ali AT; Guidozzi F
Climacteric; 2020 Apr; 23(2):116-122. PubMed ID: 31657237
[TBL] [Abstract][Full Text] [Related]
2. Polycystic ovary syndrome and metabolic disorders: A review of the literature.
Ali AT; Al-Ani O; Al-Ani F; Guidozzi F
Afr J Reprod Health; 2022 Aug; 26(8):89-99. PubMed ID: 37585035
[TBL] [Abstract][Full Text] [Related]
3. Polycystic ovary syndrome and insulin: our understanding in the past, present and future.
Mayer SB; Evans WS; Nestler JE
Womens Health (Lond); 2015 Mar; 11(2):137-49. PubMed ID: 25776288
[TBL] [Abstract][Full Text] [Related]
4. Polycystic ovary syndrome and metabolic syndrome.
Ali AT
Ceska Gynekol; 2015 Aug; 80(4):279-89. PubMed ID: 26265416
[TBL] [Abstract][Full Text] [Related]
5. [Clinical implications of polycystic ovary syndrome].
Dravecká I
Vnitr Lek; 2016; 62(5):392-7. PubMed ID: 27319232
[TBL] [Abstract][Full Text] [Related]
6. Polycystic ovary syndrome: associations with cardiovascular disease.
Benham JL; Goldberg A; Teede H; Tay CT
Climacteric; 2024 Feb; 27(1):47-52. PubMed ID: 38073517
[TBL] [Abstract][Full Text] [Related]
7. Consensus on women's health aspects of polycystic ovary syndrome (PCOS).
Amsterdam ESHRE/ASRM-Sponsored 3rd PCOS Consensus Workshop Group
Hum Reprod; 2012 Jan; 27(1):14-24. PubMed ID: 22147920
[TBL] [Abstract][Full Text] [Related]
8. Polycystic ovary syndrome, adipose tissue and metabolic syndrome.
Delitala AP; Capobianco G; Delitala G; Cherchi PL; Dessole S
Arch Gynecol Obstet; 2017 Sep; 296(3):405-419. PubMed ID: 28643028
[TBL] [Abstract][Full Text] [Related]
9. AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS, AMERICAN COLLEGE OF ENDOCRINOLOGY, AND ANDROGEN EXCESS AND PCOS SOCIETY DISEASE STATE CLINICAL REVIEW: GUIDE TO THE BEST PRACTICES IN THE EVALUATION AND TREATMENT OF POLYCYSTIC OVARY SYNDROME - PART 2.
Goodman NF; Cobin RH; Futterweit W; Glueck JS; Legro RS; Carmina E; ; ;
Endocr Pract; 2015 Dec; 21(12):1415-26. PubMed ID: 26642102
[TBL] [Abstract][Full Text] [Related]
10. Cardiometabolic risks in PCOS: a review of the current state of knowledge.
Kakoly NS; Moran LJ; Teede HJ; Joham AE
Expert Rev Endocrinol Metab; 2019 Jan; 14(1):23-33. PubMed ID: 30556433
[TBL] [Abstract][Full Text] [Related]
11. Metabolic consequences of obesity and insulin resistance in polycystic ovary syndrome: diagnostic and methodological challenges.
Jeanes YM; Reeves S
Nutr Res Rev; 2017 Jun; 30(1):97-105. PubMed ID: 28222828
[TBL] [Abstract][Full Text] [Related]
12. Cardiometabolic risk in patients with polycystic ovary syndrome.
Ozegowska K; Pawelczyk L
Ginekol Pol; 2015 Nov; 86(11):840-8. PubMed ID: 26817316
[TBL] [Abstract][Full Text] [Related]
13. Diagnostic features of polycystic ovary syndrome in adolescents (review).
Beltadze K; Barbakadze L
Georgian Med News; 2015 Jan; (238):32-4. PubMed ID: 25693210
[TBL] [Abstract][Full Text] [Related]
14. Elevated fasting insulin is associated with cardiovascular and metabolic risk in women with polycystic ovary syndrome.
Rasool SUA; Ashraf S; Nabi M; Rashid F; Fazili KM; Amin S
Diabetes Metab Syndr; 2019; 13(3):2098-2105. PubMed ID: 31235143
[TBL] [Abstract][Full Text] [Related]
15. Obesity and polycystic ovary syndrome.
Vrbikova J; Hainer V
Obes Facts; 2009; 2(1):26-35. PubMed ID: 20054201
[TBL] [Abstract][Full Text] [Related]
16. Polycystic ovarian syndrome.
Khan KA; Stas S; Kurukulasuriya LR
J Cardiometab Syndr; 2006; 1(2):125-30; quiz 131-2. PubMed ID: 17679815
[TBL] [Abstract][Full Text] [Related]
17. Depression in Girls With Obesity and Polycystic Ovary Syndrome and/or Type 2 Diabetes.
Benson J; Severn C; Hudnut-Beumler J; Simon SL; Abramson N; Shomaker LB; Gulley LD; Taylor A; Kelsey MM; Nadeau KJ; Zeitler PS; Pyle L; Cree-Green M
Can J Diabetes; 2020 Aug; 44(6):507-513. PubMed ID: 32792104
[TBL] [Abstract][Full Text] [Related]
18. The role of insulin and selected adipocytokines in patients with polycystic ovary syndrome (PCOS) - a literature review.
Ozegowska KE; Pawelczyk LA
Ginekol Pol; 2015 Apr; 86(4):300-4. PubMed ID: 26117990
[TBL] [Abstract][Full Text] [Related]
19. Medical comorbidity in polycystic ovary syndrome with special focus on cardiometabolic, autoimmune, hepatic and cancer diseases: an updated review.
Glintborg D; Andersen M
Curr Opin Obstet Gynecol; 2017 Dec; 29(6):390-396. PubMed ID: 28901968
[TBL] [Abstract][Full Text] [Related]
20. Polycystic Ovary Syndrome as a systemic disease with multiple molecular pathways: a narrative review.
Carvalho LML; Dos Reis FM; Candido AL; Nunes FFC; Ferreira CN; Gomes KB
Endocr Regul; 2018 Oct; 52(4):208-221. PubMed ID: 31517612
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
